2[2]Juliano RL, Ling V. A surface glycoprotein modulating drug permeability in chinese hamster ovary cell mutants[J]. Biochem Biophys Acta, 1976,455(1):152～162
3[3]Chen CJ, Chin JE, Ueda K, et al. Internal duplication and homology with bacterial transport proteins in the MDR-1 gene from MDR human cells[J]. Cell, 1986, 47(3):381～389
4[5]Raaijmakers HGP, Izquierdo MAI, Lokhorst HM, et al. Lung-resistance related protein expression is anegative predictive factor for response to conventional low but not to intensified dose alkylating chemotherapy in multiple myeloma [J]. Blood, 1998, 91 (3):1029 ～ 1036
5[7]Frei E Ⅲ, Antman K, Teicher B, et al. Bone marrow autotransplantatinon for solid tumors-prospects [J]. J Clin Oncol, 1989, 7(4):515～526
6[8]Codman AJ, godie JH. Impact of dose-intense chemotherapy on the development of permanent drug resistance [J]. Semin Oncol,1987, 14(4 Suppl 4):29～33
7[9]Peters WP, Ross M, Vredenburgh JJ, et al. High-dose chemotherapy and autlogous bone morrow support as consolidation after standard-dose adjuvant therapy for high risk prmiary breastcancer[J].J Clin Oncol, 1993, 11(6):1132～1143
8[10]Venturini M, Mastro LD, Melioli G, et al. Release of peripheral blood stem cells during standard dose cyclophosphamide,epidoxorublcin 5-fluorouracil regimen plus granulocyte coony-stmiulating factor for breast cancer therapy[J]. Cancer, 1994, 74(8):2300～2306
